Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veramyst in Allergic Rhinitis Nasal Challenge
NCT00791973Phase 4Completed
- Sponsor
- University of Chicago
- Start
- Nov 2008
- Primary completion
- Apr 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluticasone in allergic rhinitis (AR), sponsored by University of Chicago. Started Nov 2008; status: completed.
02
Drugs
fluticasone
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00791973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00791973.